The WACC of BridgeBio Pharma Inc (BBIO) is 7.7%.
| Range | Selected | |
| Cost of equity | 7.40% - 9.60% | 8.50% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 7.00% - 7.40% | 7.20% |
| WACC | 6.9% - 8.6% | 7.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.77 | 0.84 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.40% | 9.60% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.32 | 0.32 |
| Cost of debt | 7.00% | 7.40% |
| After-tax WACC | 6.9% | 8.6% |
| Selected WACC | 7.7% | |